Profile Previews

Get a glimpse into our company and investor data—powered by the PitchBook Platform

Orbus Therapeutics

Orbus Therapeutics
2012 FOUNDED
PRIVATE STATUS
1-10 EMPLOYEES
Later Stage VC LATEST DEAL TYPE
$18.5M LATEST DEAL AMOUNT
5 INVESTORS
Description

Developer of medicinal products designed to improve the health and quality of life for patients with rare diseases. The company's medical product is an irreversible inhibitor of ornithine decarboxylase (ODC) that delays or freezes tumor growth by inhibiting the production of the enzyme, enabling medical professionals to prevent tumor growth in certain types of cancer.

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Drug Discovery
Other Industries
Discovery Tools (Healthcare)
Primary Office
  • 2479 East Bayshore Road
  • Suite 105
  • Palo Alto, CA 94303
  • United States

+1 (650) 000-0000
Request full access to PitchBook

You’re viewing a free company profile from the PitchBook Platform. To explore Orbus Therapeutics’s full profile, request a free trial.

Orbus Therapeutics Valuation and Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
2. Later Stage VC 20-Mar-2019 $18.5M 0000 0000 Completed Clinical Trials - Phase 3
1. Early Stage VC (Series A) 19-Aug-2015 000.00 000.00 0000 Completed Startup
To view this company’s complete deal history including valuation and funding, request access »

Orbus Therapeutics Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate (%) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion
Price
% Owned
Series A-2 00,000,000 00.000000 00.00 00.00 00 00.00 00.000
Series A 00,000,000 00.000000 00.00 00.00 00 00.00 00.000
To view this company’s complete Cap Table, request access »

Orbus Therapeutics Competitors (1)

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
0000000 Formerly VC-backed San Diego, CA 00 00000 000000&0 00000
To view this company’s complete list of competitors, request access »

Orbus Therapeutics Investors (5)

Investor Name Investor Type Holding Investor Since Participating Rounds Board
Seat
Contact
Info
Agent Capital Venture Capital Minority 000 0000 000000 0
Adams Street Partners Fund of Funds Minority 000 0000 000000 0
Ernest Mario Angel (individual) Minority 000 0000 000000 0
H.I.G. BioHealth Partners Venture Capital Minority 000 0000 000000 0
Longitude Capital Venture Capital Minority 000 0000 000000 0

Orbus Therapeutics Executive Team (2)

Name Title Board
Seat
Contact
Info
Robert Myers Co-Founder, President, Chief Executive Officer & Board Member
Jason Levin Co-Founder, Board Member & Chief Operating Officer

Orbus Therapeutics Board Members (6)

Name Representing Role Since Contact
Info
Ernest Mario Ph.D Self Chairman 000 0000
Jason Levin Orbus Therapeutics Co-Founder, Board Member & Chief Operating Officer 000 0000
Michael Wasserman Ph.D H.I.G. BioHealth Partners Board Member 000 0000
Patrick Enright Longitude Capital Board Member 000 0000
Robert Myers Orbus Therapeutics Co-Founder, President, Chief Executive Officer & Board Member 000 0000
You’re viewing 5 of 6 board members. Get the full list »